Yes, Medicare Part B covers J3420 for medically necessary indications including pernicious anemia (D51.0), documented vitamin B12 deficiency (E53.8), and malabsorption syndromes that prevent adequate oral absorption
Other studies have suggested beneficial effects of L-carnitine supplementation on inflammatory parameters 55 , in the secondary prevention of CVD 54,56 , in diabetes mellitus 57 , on serum lipid profile in hemodialysis patients 58 , for adults with end-stage kidney disease on hemodialysis 59 or for patients in maintenance hemodialysis 60 , though detailed analysis of whether the carnitine was provided in oral vs intravenous supplementation, bypassing the gut microbiota, has not been extensively evaluated
Click to expand full analysis sheet
Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management
5-Amino-1MQ is produced under controlled manufacturing conditions designed to promote consistency across production lots and reduce variability between batches